Socks designed by a vascular surgeon at University College London that improve circulation for hospital patients and professional soccer players make money for the university. A gene-therapy drug to treat a rare form of inherited blindness very likely will not. A 15-year research project that involves banking and analyzing blood-serum samples and health records of 200,000 women across the British Isles doesn't generate a return now, but someday it probably will.
University College London Business, the institution's technology-transfer company, plays a role in those and hundreds of other projects. And the mix of the financially profitable and socially relevant in its portfolio is no accident.
To read the full, original article click on this link: A Tech-Transfer Operation Where Profits Aren't the Only Goal - Administration - The Chronicle of Higher Education
Author: Goldie Blumenstyk
